National Comprehensive Cancer Network

Educational Events & Programs

NCCN 10th Annual Congress:
Hematologic Malignancies™

October 16 – 17, 2015
San Francisco Marriott Marquis
780 Mission Street
San Francisco, CA 94103


Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

Co-Chairs:
Ranjana H. Advani, MD
Stanford Cancer Institute

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

AGENDA*:

Friday, October 16, 2015

4:30 – 6:00 PM

Registration, Exhibits, and Refreshments

6:00 – 6:15 PM

Opening Remarks
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

Ranjana H. Advani, MD
Stanford Cancer Institute

6:15 – 7:05 PM

Patient Case Studies & Panel Discussion
(Double-hit Lymphoma, T-cell Lymphoma, Mantle Cell Lymphoma)

Panelists:
Ranjana H. Advani, MD
Stanford Cancer Institute

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

7:10 – 7:35 PM

Optimizing Small Molecular Inhibitor Therapy for Chronic Lymphocytic Leukemia
William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center

7:40 – 8:05 PM

Evolving Therapies for Follicular Lymphoma
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

8:10 – 8:35 PM

Management of HIV-associated Non-Hodgkin’s Lymphomas
Lawrence D. Kaplan, MD
UCSF Helen Diller Family Comprehensive Cancer Center

 

Saturday, October 17, 2015

7:00 – 8:00 AM

Registration, Exhibits, and Refreshments

8:00 – 8:05 AM

Opening Remarks
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

Ranjana H. Advani, MD
Stanford Cancer Institute

8:05 – 8:55 AM

Patient Case Studies & Panel Discussion 
(Myeloproliferative Disorders, Elderly Myelofibrosis, Hemophagocytic Syndromes)

Panelists:
Joseph C. Alvarnas, MD
City of Hope Comprehensive Cancer Center

Peter L. Greenberg, MD
Stanford Cancer Institute

9:00 – 9:25 AM

Evolving Targeted Management of Acute Myeloid Leukemia

9:30 – 9:55 AM

Management of Myelodysplastic Syndromes
Peter L. Greenberg, MD
Stanford Cancer Institute

9:55 – 10:25 AM

Break and Exhibits

10:25 – 10:50 AM

Management of Acute Lymphoblastic Leukemia
Joseph C. Alvarnas, MD
City of Hope Comprehensive Cancer Center

10:55 – 11:45 AM

Survivorship Issues: Late Effects of Curative Therapy in Lymphoma Survivors
Glen J. Peterson, NP
University of Colorado Cancer Center

11:45 AM – 1:00 PM

Lunch and Exhibits

1:00 – 1:50 PM

Patient Case Studies & Panel Discussion 
(Amyloidosis, POEMS Syndrome, Plasmacytoma)

Panelists:
William Bensinger, MD
Fred Hutchinson Cancer Research Center/
Seattle Cancer Care Alliance

Keith K. Stewart, MB, ChB
Mayo Clinic

1:55 – 2:20 PM

Advances in Waldenström's Macroglobulinemia
Steven P. Treon, MD, PhD
Dana-Farber/Brigham and Women’s Cancer Center
Massachusetts General Hospital Cancer Center

2:25 – 2:50 PM

Management of Multiple Myeloma
William Bensinger, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

2:55 – 3:20 PM

Bone Health in Patients with Multiple Myeloma
Keith K. Stewart, MB, ChB
Mayo Clinic

3:20 – 3:35 PM

Break and Exhibits

3:35 – 4:00 PM

Diagnosis and Management of Castleman Disease
Jeremy S. Abramson, MD
Massachusetts General Hospital Cancer Center

4:05 – 4:30 PM

PET-Guided Treatment Approach for Advanced Stage Classical Hodgkin Lymphoma
Ranjana H. Advani, MD
Stanford Cancer Institute

4:35 – 5:00 PM

Targeted Therapies for Relapsed or Refractory Classical Hodgkin Lymphoma
Craig H. Moskowitz, MD
Memorial Sloan Kettering Cancer Center

5:00 PM

Closing Remarks  
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

Ranjana H. Advani, MD
Stanford Cancer Institute

 

This agenda is subject to change. Faculty will be updated as confirmed.


Intended Audience

This congress is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.

Accreditation Information

This congress is approved for AMA PRA Category 1 Credit™ and is also certified for nurses and pharmacists. Learn more.

Fees

Reserve your seat by Friday, September 11, 2015 to receive the Early Bird Registration rate. As a benefit of membership, NCCN extends a 20% discount off the registration fee to staff employed at NCCN Member Institutions. Learn more.

Free Registration for Fellows

Fellows must provide a letter on institution letterhead from their Director stating that they are a Fellow in good standing. Fellows must register by Friday, September 11, 2015. Learn more.

Accommodations

NCCN has a limited number of rooms reserved for registered attendees for the nights of Friday, October 16th and Saturday, October 17th at a discounted rate of $269 per night. Please book your room by Thursday, September 24th to take advantage of this special rate. Early booking is strongly encouraged. Learn more.

Please refer to the complete accreditation, fee, and accommodations details available here for more information.


Exhibitor Information

Organizations who are interested in exhibiting at NCCN programs are encouraged to contact Jennifer Tredwell, Senior Director, Marketing.


Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.